000			02292 a2200613 4500
005			20250515235515.0
264		0	_c20110103
008			201101s 0 0 eng d
022			_a1744-8069
024	7		_a10.1186/1744-8069-6-48 _2doi
040			_aNLM _beng _cNLM
100	1		_aNair, Asha
245	0	0	_aFamilial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain. _h[electronic resource]
260			_bMolecular pain _cAug 2010
300			_a48 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenosine Triphosphate _xmetabolism
650	0	4	_aAgatoxins
650	0	4	_aAmino Acid Substitution _xgenetics
650	0	4	_aAnimals
650	0	4	_aCalcineurin _xmetabolism
650	0	4	_aCalcium Channels, N-Type
650	0	4	_aCalcium Channels, P-Type _xgenetics
650	0	4	_aCalcium Channels, Q-Type _xgenetics
650	0	4	_aCalcium Signaling _xdrug effects
650	0	4	_aCalcium-Calmodulin-Dependent Protein Kinase Type 2 _xmetabolism
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aGanglia, Sensory _xdrug effects
650	0	4	_aGene Knock-In Techniques
650	0	4	_aIntracellular Space _xdrug effects
650	0	4	_aIon Channel Gating _xdrug effects
650	0	4	_aMembrane Potentials _xdrug effects
650	0	4	_aMice
650	0	4	_aMigraine with Aura _xcomplications
650	0	4	_aMutant Proteins _xmetabolism
650	0	4	_aMutation _xgenetics
650	0	4	_aPain _xcomplications
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPhosphoserine _xmetabolism
650	0	4	_aPotassium _xmetabolism
650	0	4	_aReceptors, Purinergic P2X3 _xmetabolism
650	0	4	_aSensory Receptor Cells _xdrug effects
650	0	4	_aSpider Venoms _xpharmacology
650	0	4	_aTrigeminal Nerve _xdrug effects
700	1		_aSimonetti, Manuela
700	1		_aBirsa, Nicol
700	1		_aFerrari, Michel D
700	1		_avan den Maagdenberg, Arn M J M
700	1		_aGiniatullin, Rashid
700	1		_aNistri, Andrea
700	1		_aFabbretti, Elsa
773	0		_tMolecular pain _gvol. 6 _gp. 48
856	4	0	_uhttps://doi.org/10.1186/1744-8069-6-48 _zAvailable from publisher's website
999			_c20071020 _d20071020